Literature DB >> 21681430

Synergism between paraoxonase Arg 192 and the angiotensin converting enzyme D allele is associated with severity of coronary artery disease.

Asad Vaisi-Raygani1, Zohreh Rahimi, Haidar Tavilani, Hadiss Vaisi-Raygani, A Kiani, M Aminian, E Shakiba, Y Shakiba, Tayebeh Pourmotabbed.   

Abstract

We have previously shown that angiotensin-converting enzyme (ACE) gene D allele is an independent risk factor for early onset coronary artery disease (CAD). Little is known about the concomitant presence of the ACE gene D allele and paraoxonase (PON1) codon 192 arginine (Arg) on the severity of CAD. Regarding the high rate of CAD among Iranians the aim of present study was to examine the hypothesis of synergistic effects between ACE-D and PON1-Arg alleles on predisposition and the severity of CAD in our population. The PON1 192 and ACE insertion/deletion (I/D) genotypes were detected by PCR-RFLP and PCR, respectively in 414 individuals undergoing their first coronary angiography. Patients were placed into one of two groups: CAD and control without CAD or diabetes. We mentioned the synergistic effects of both genes and not ACE gene alone is a risk factor for CAD. We found that PON1 Arg 192 and ACE D allele act synergistically to increase the risk of CAD (OR 1.3, P = 0.044). Our results showed a significant correlation between the possession of both PON1 192 Arg and the ACE D allele and the extent of CAD in CAD patients and CAD subjects without diabetes, represented by the increased frequency of three-vessel disease with OR 2.7, P = 0.046; χ(2) = 4, P = 0.046 and OR 2.4, P = 0.051; χ(2) = 3.8, P = 0.051, respectively. We found that PON1 Arg 192 and ACE D alleles act synergistically to increase the risk of CAD in CAD patients and CAD subjects without diabetes from west of Iran, who have high frequency of three-vessel disease. Our data suggest that PON1 192 Arg and the ACE D allele in combination with each other can be important independent risk factor for severity of CAD in patients carrying both PON1 192 Arg and the ACE D allele in a west population of Iran.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21681430     DOI: 10.1007/s11033-011-1027-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  53 in total

1.  The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study.

Authors:  S M Herrmann; H Blanc; O Poirier; D Arveiler; G Luc; A Evans; P Marques-Vidal; J M Bard; F Cambien
Journal:  Atherosclerosis       Date:  1996-10-25       Impact factor: 5.162

Review 2.  Paraoxonases: structure, gene polymorphism & role in coronary artery disease.

Authors:  Nidhi Gupta; Kirandip Gill; Surjit Singh
Journal:  Indian J Med Res       Date:  2009-10       Impact factor: 2.375

3.  Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

Authors:  D K Sanghera; N Saha; C E Aston; M I Kamboh
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-06       Impact factor: 8.311

4.  Angiotensin converting enzyme I/D, angiotensinogen M235T and AT1-R A/C1166 gene polymorphisms in patients with acromegaly.

Authors:  Sebahat Turgut; Fulya Akın; Raziye Akcılar; Ceylan Ayada; Günfer Turgut
Journal:  Mol Biol Rep       Date:  2010-04-02       Impact factor: 2.316

5.  Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus.

Authors:  M Odawara; Y Tachi; K Yamashita
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

6.  Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?

Authors:  D Osei-Hyiaman; L Hou; F Mengbai; R Zhiyin; Z Zhiming; K Kano
Journal:  Eur J Endocrinol       Date:  2001-06       Impact factor: 6.664

7.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

8.  Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians.

Authors:  Manickaraj AshokKumar; Navaneethan Gnana Veera Subhashini; Ramineni SaiBabu; Arabandi Ramesh; Kotturathu Mammen Cherian; Cyril Emmanuel
Journal:  Mol Biol Rep       Date:  2009-08-22       Impact factor: 2.316

9.  Clinical and epidemiological characteristics of juvenile myocardial infarction in Italy: the GISSI experience.

Authors:  M Imazio; M Bobbio; S Bergerone; S Barlera; A P Maggioni
Journal:  G Ital Cardiol       Date:  1998-05

10.  Serum butyrylcholinesterase activity and phenotype associations with lipid profile in stroke patients.

Authors:  Asad Vaisi-Raygani; Heidar Tavilani; Mahine Zahrai; Zohreh Rahimi; Nasrin Sheikh; Mahdi Aminian; Tayebeh Pourmotabbed
Journal:  Clin Biochem       Date:  2008-11-12       Impact factor: 3.281

View more
  2 in total

1.  R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke.

Authors:  Abdolkarim Mahrooz; Ghorban Gohari; Mohammad-Bagher Hashemi; Mehryar Zargari; Hadis Musavi; Mahmoud Abedini; Ahad Alizadeh
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

2.  Association of Paraoxonase-1 Genotype and Phenotype with Angiogram Positive Coronary Artery Disease.

Authors:  Sara Saffar Soflaei; Mojtaba Baktashian; Kiana Hosseinpour Moghaddam; Maryam Saberi-Karimian; Negin Kosari; Seyed Mohammad Hashemi; Mohsen Mouhebati; Mahsa Amini; Mashallah Dehghani; Habibollah Esmaily; Mahmoud Ebrahimi; Homa Falsoleiman; Abolfazl Nosrati-Tirkani; Fatemeh Sadabadi; Gordon A Ferns; Mansoor Salehi; Alireza Pasdar; Majid Ghayour-Mobarhan
Journal:  Arq Bras Cardiol       Date:  2022-09-02       Impact factor: 2.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.